Order:
Disambiguations
Gill Haddow [6]G. Haddow [1]
  1.  43
    3D bioprint me: a socioethical view of bioprinting human organs and tissues.Niki Vermeulen, Gill Haddow, Tirion Seymour, Alan Faulkner-Jones & Wenmiao Shu - 2017 - Journal of Medical Ethics 43 (9):618-624.
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  2.  6
    Implantable Smart Technologies (IST): Defining the ‘Sting’ in Data and Device.Leah Gilman, Shawn H. E. Harmon & Gill Haddow - 2016 - Health Care Analysis 24 (3):210-227.
    In a world surrounded by smart objects from sensors to automated medical devices, the ubiquity of ‘smart’ seems matched only by its lack of clarity. In this article, we use our discussions with expert stakeholders working in areas of implantable medical devices such as cochlear implants, implantable cardiac defibrillators, deep brain stimulators and in vivo biosensors to interrogate the difference facets of smart in ‘implantable smart technologies’, considering also whether regulation needs to respond to the autonomy that such artefacts carry (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  3.  39
    "Because you're worth it?" The taking and selling of transplantable organs.G. Haddow - 2006 - Journal of Medical Ethics 32 (6):324-328.
    In the UK, the legal processes underpinning the procurement system for cadaveric organs for transplantation and research after death are under review. The review originated after media reports of hospitals, such as Alder Hey and Bristol, retaining organs after death without the full, informed consent of relatives. The organ procurement systems for research and transplantation are separate and distinct, but given that legal change will be applicable to both, some have argued now is the time to introduce alternative organ transplant (...)
    Direct download (8 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  4.  31
    Implantable Smart Technologies : Defining the ‘Sting’ in Data and Device.Gill Haddow, Shawn H. E. Harmon & Leah Gilman - 2016 - Health Care Analysis 24 (3):210-227.
    In a world surrounded by smart objects from sensors to automated medical devices, the ubiquity of ‘smart’ seems matched only by its lack of clarity. In this article, we use our discussions with expert stakeholders working in areas of implantable medical devices such as cochlear implants, implantable cardiac defibrillators, deep brain stimulators and in vivo biosensors to interrogate the difference facets of smart in ‘implantable smart technologies’, considering also whether regulation needs to respond to the autonomy that such artefacts carry (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  5.  37
    ‘Nothing is really safe’: a focus group study on the processes of anonymizing and sharing of health data for research purposes.Gill Haddow, Ann Bruce, Shiva Sathanandam & Jeremy C. Wyatt - 2011 - Journal of Evaluation in Clinical Practice 17 (6):1140-1146.
  6.  50
    Stakeholder perspectives on new ways of delivering unscheduled health care: the role of ownership and organizational identity.Gill Haddow, Catherine A. O'Donnell & David Heaney - 2007 - Journal of Evaluation in Clinical Practice 13 (2):179-185.
  7. Tokens of trust or token trust? Public consultation and "generation Scotland".Gill Haddow & Sarah Cunningham-Burley - 2008 - In Julie Brownlie, Alexandra Greene & Alexandra Howson (eds.), Researching Trust and Health. Routledge.
     
    Export citation  
     
    Bookmark